Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular

Background: Vitamin K antagonists such as acenocoumarol and warfarin are usually indicated for the treatment of Atrial Fibrillation (AF). The Therapeutic Range Time (TRT) is a quality of treatment indicator. Values greater than 65% are associated with significantly lower stroke and bleeding rates. Proper pharmaceutical care improves TRT. Aim: To evaluate the impact of pharmaceutical care in patients with AF treated with acenocoumarol. Material and Methods: We studied 41 patients using acenocoumarol for AF aged 71 ± 11 years (43% women). They received pharmaceutical counseling during 12 weeks. TRT was calculated retrospectively for the year before counseling and prospectively during the intervention period. Results: After receiving pharmaceutical counseling TRT improved from 29% at baseline to 46% at the end of the intervention (p < 0.01). After pharmaceutical care, the adherence of patients to drug treatment improved from 27% at baseline to 85% at the end of the study. The user satisfaction survey of the pharmaceutical care received showed a high degree of patient satisfaction. Conclusions: Pharmaceutical care in patients with oral anticoagulant treatment improves TRT of anticoagulation. It is accepted and positively evaluated by patients.

Saved in:
Bibliographic Details
Main Authors: Leal,Bryan, Torres,Héctor, Roco,Ángela, Román,Ricardo, Rojo,Mario, Nieto,Elena, Quiñones,Luis
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2021
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500724
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872021000500724
record_format ojs
spelling oai:scielo:S0034-988720210005007242021-11-03Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricularLeal,BryanTorres,HéctorRoco,ÁngelaRomán,RicardoRojo,MarioNieto,ElenaQuiñones,Luis Acenocoumarol Anticoagulants Atrial Fibrillation Pharmaceutical Services Background: Vitamin K antagonists such as acenocoumarol and warfarin are usually indicated for the treatment of Atrial Fibrillation (AF). The Therapeutic Range Time (TRT) is a quality of treatment indicator. Values greater than 65% are associated with significantly lower stroke and bleeding rates. Proper pharmaceutical care improves TRT. Aim: To evaluate the impact of pharmaceutical care in patients with AF treated with acenocoumarol. Material and Methods: We studied 41 patients using acenocoumarol for AF aged 71 ± 11 years (43% women). They received pharmaceutical counseling during 12 weeks. TRT was calculated retrospectively for the year before counseling and prospectively during the intervention period. Results: After receiving pharmaceutical counseling TRT improved from 29% at baseline to 46% at the end of the intervention (p < 0.01). After pharmaceutical care, the adherence of patients to drug treatment improved from 27% at baseline to 85% at the end of the study. The user satisfaction survey of the pharmaceutical care received showed a high degree of patient satisfaction. Conclusions: Pharmaceutical care in patients with oral anticoagulant treatment improves TRT of anticoagulation. It is accepted and positively evaluated by patients.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.5 20212021-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500724es10.4067/s0034-98872021000500724
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Leal,Bryan
Torres,Héctor
Roco,Ángela
Román,Ricardo
Rojo,Mario
Nieto,Elena
Quiñones,Luis
spellingShingle Leal,Bryan
Torres,Héctor
Roco,Ángela
Román,Ricardo
Rojo,Mario
Nieto,Elena
Quiñones,Luis
Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
author_facet Leal,Bryan
Torres,Héctor
Roco,Ángela
Román,Ricardo
Rojo,Mario
Nieto,Elena
Quiñones,Luis
author_sort Leal,Bryan
title Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_short Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_full Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_fullStr Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_full_unstemmed Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_sort impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
description Background: Vitamin K antagonists such as acenocoumarol and warfarin are usually indicated for the treatment of Atrial Fibrillation (AF). The Therapeutic Range Time (TRT) is a quality of treatment indicator. Values greater than 65% are associated with significantly lower stroke and bleeding rates. Proper pharmaceutical care improves TRT. Aim: To evaluate the impact of pharmaceutical care in patients with AF treated with acenocoumarol. Material and Methods: We studied 41 patients using acenocoumarol for AF aged 71 ± 11 years (43% women). They received pharmaceutical counseling during 12 weeks. TRT was calculated retrospectively for the year before counseling and prospectively during the intervention period. Results: After receiving pharmaceutical counseling TRT improved from 29% at baseline to 46% at the end of the intervention (p < 0.01). After pharmaceutical care, the adherence of patients to drug treatment improved from 27% at baseline to 85% at the end of the study. The user satisfaction survey of the pharmaceutical care received showed a high degree of patient satisfaction. Conclusions: Pharmaceutical care in patients with oral anticoagulant treatment improves TRT of anticoagulation. It is accepted and positively evaluated by patients.
publisher Sociedad Médica de Santiago
publishDate 2021
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500724
work_keys_str_mv AT lealbryan impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular
AT torreshector impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular
AT rocoangela impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular
AT romanricardo impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular
AT rojomario impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular
AT nietoelena impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular
AT quinonesluis impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular
_version_ 1755988688600301568